Pharmaceutical costs expected to rise 3.35% in 2026: Vizient

(By: Alexandra Murphy for Becker’s Hospital Review)

Pharmaceutical prices are expected to rise by 3.35% in 2026, according to Vizient’s latest Pharmacy Market Outlet report, released in July.

The report found that price pressures are easing in certain areas due to biosimilar competition, especially with respect to drugs such as Humira and Stelara. High-use inpatient medications are also expected to see price declines. Pediatric drugs are expected to have the highest inflation rate, at 3.93%, while prices in the self-administered medication segment dropped from 4.53% to 3.3%. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.